Amlodipine and Valsartan (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Amlodipine and Valsartan drug offered from Teva Pharmaceuticals USA, Inc.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Amlodipine and Valsartan |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; VALSARTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-03-30 |
| END MARKETING DATE: | 0000-00-00 |
Amlodipine and Valsartan HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amlodipine and Valsartan from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 160(mg/1; mg/1) |
| START MARKETING DATE: | 2015-03-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-7690_c08036de-d264-47b2-802e-d4776e1f8dcf |
| PRODUCT NDC: | 0093-7690 |
| APPLICATION NUMBER: | ANDA091235 |
Other AMLODIPINE BESYLATE; VALSARTAN Pharmaceutical Manufacturers / Labelers:
